scholarly journals Endoscopic ultrasound assessment and tissue acquisition of mediastinal and abdominal lymph nodes

2021 ◽  
Vol 13 (10) ◽  
pp. 1475-1491
Author(s):  
Giacomo Tamanini ◽  
Anna Cominardi ◽  
Nicole Brighi ◽  
Pietro Fusaroli ◽  
Andrea Lisotti
Author(s):  
Stefano Francesco Crinó ◽  
Alessandro Brandolese ◽  
Filippo Vieceli ◽  
Salvatore Paiella ◽  
Maria Cristina Conti Bellocchi ◽  
...  

Abstract Background and Study Aims On contrast-enhanced imaging studies, nonhypovascular (i. e., isovascular and hypervascular) patterns can be observed in solid pancreatic lesions (SPLs) of different nature, prognosis, and management. We aimed to identify endoscopic ultrasound (EUS) features of nonhypovascular SPLs associated with malignancy/aggressiveness. The secondary aims were EUS tissue acquisition (EUS-TA) outcome and safety in this setting of patients. Patients and Methods This prospective observational study included patients with nonhypovascular SPLs detected on cross-sectional imaging and referred for EUS-TA. Lesion features (size, site, margins, echotexture, vascular pattern, and upstream dilation of the main pancreatic duct) were recorded. Malignancy/aggressiveness was determined by evidence of carcinoma at biopsy/surgical pathology, signs of aggressiveness (perineural invasion, lymphovascular invasion, and/or microscopic tumor extension/infiltration or evidence of metastatic lymph nodes) in the surgical specimen, radiologic detection of lymph nodes or distant metastases, and/or tumor growth > 5 mm/6 months. Uni- and multivariate analyses were performed to assess the primary aim. Results A total of 154 patients with 161 SPLs were enrolled. 40 (24.8 %) lesions were defined as malignant/aggressive. Irregular margins and size > 20 mm were independent factors associated with malignancy/aggressiveness (p < 0.001, OR = 5.2 and p = 0.003, OR = 2.1, respectively). However, size > 20 mm was not significant in the subgroup of other-than-neuroendocrine tumor (NET) lesions. The EUS-TA accuracy was 92 %, and the rate of adverse events was 4 %. Conclusion Irregular margins on EUS are associated with malignancy/aggressiveness of nonhypovascular SPLs. Size > 20 mm should be considered a malignancy-related feature only in NET patients. EUS-TA is safe and highly accurate for differential diagnosis in this group of patients.


Open Medicine ◽  
2015 ◽  
Vol 10 (1) ◽  
Author(s):  
Zhiguo Wang ◽  
Chunmeng Jiang

AbstractEUS is a useful tool for diagnosis of mediastinal diseases. EUS-FNA plays an important role in staging of lung cancer and in tissue acquisition in patients with mediastinal masses. In this review, the following issues will be addressed: EUS-FNA and EBUS-TBNA, metastatic mediastinal lymph nodes diagnosed by EUS, EUS in assessment of mediastinal lymph node status for staging of lung cancer, mediastinal lymphoma diagnosed by EUS, sarcoidosis and tuberculosis diagnosed by EUS.


2017 ◽  
Vol 23 (31) ◽  
pp. 5755 ◽  
Author(s):  
Yung Ka Chin ◽  
Julio Iglesias-Garcia ◽  
Daniel de la Iglesia ◽  
Jose Lariño-Noia ◽  
Ihab Abdulkader-Nallib ◽  
...  

2021 ◽  
Vol 10 (5) ◽  
pp. 1076
Author(s):  
Akashi Fujita ◽  
Shomei Ryozawa ◽  
Masafumi Mizuide ◽  
Yuki Tanisaka ◽  
Tomoya Ogawa ◽  
...  

Currently, endoscopic ultrasound (EUS) has become widely accepted and has considerable advantages over computed tomography (CT) and other imaging modalities, given that it enables echostructure assessment in lesions with <1 cm diameter and permits high resolution imaging. EUS-guided tissue acquisition (EUS-TA) provides consistent results under ultrasound guidance and has been considered more effective compared to CT- or ultrasound-guided lesion biopsy. Moreover, complication rates, including pancreatitis and bleeding, have been extremely low, with <1% morbidity and mortality rates, thereby suggesting the exceptional overall safety of EUS-TA. The aggressive use of EUS for various lesions has been key in facilitating early diagnosis and therapy. This review summarizes the diagnostic ability of EUS for pancreatic solid lesions, subepithelial lesions, and lymph nodes where it is mainly used. EUS has played an important role in diagnosing these lesions and planning treatment strategies. Future developments in EUS imaging technology, such as producing images close to histopathological findings, are expected to further improve its diagnostic ability. Moreover, tissue acquisition via EUS is expected to be used for precision medicine, which facilitates the selection of an appropriate therapeutic agent by increasing the amount of tissue collected and improving genetic analysis.


Endoscopy ◽  
2006 ◽  
Vol 39 (S 1) ◽  
Author(s):  
P Magno ◽  
CW Ko ◽  
S Giday ◽  
SB Jagannath ◽  
MI Canto ◽  
...  

Endoscopy ◽  
2012 ◽  
Vol 44 (08) ◽  
pp. 759-766 ◽  
Author(s):  
M. Larsen ◽  
C. Fristrup ◽  
T. Hansen ◽  
C. Hovendal ◽  
M. Mortensen

Medicine ◽  
2016 ◽  
Vol 95 (44) ◽  
pp. e5246 ◽  
Author(s):  
Tae Won Lim ◽  
Cheol Woong Choi ◽  
Dae Hwan Kang ◽  
Hyung Wook Kim ◽  
Su Bum Park ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document